Ischemic Optic Neuropathy: A Review of Current and Potential Future Pharmacotherapies
Pharmaceuticals · 27.09.2024 · 17 (10) · 1281
DOI: 10.3390/ph17101281 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 27.09.2024. Verfasst von Omar Badla und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School Medicine, Miami, FL 33136, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The treatment of arteritic anterior ischemic optic neuropathy (AAION), non-arteritic ischemic optic neuropathy (NAAION), and posterior ischemic optic neuropathy (PION) is a topic of ongoing research with mixed evidence on some pharmacotherapies and a need for more consensus. This manuscript provides an overview of these conditions’ current, potential future, and attempted pharmacotherapies. AAION’s current treatment regimen consists of high-dose steroids, with methotrexate, tocilizumab, and abatacept, being the most viable steroid-sparing therapy candidates. As for NAAION, the treatments being tried are vast, with mixed evidence supporting each modality. Similarly, despite the various treatment options explored, there still needs to be a universally effective therapy for PION. More research is needed to formulate an agreed-upon treatment regimen for these conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School Medicine, Miami, FL 33136, USA.
- Miami Integrative Metabolomics Research Center, Miami, FL 33136, USA.
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.
- Graduate Program in Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
ORCID-Profile: Omar Badla, Beshr Abdulaziz Badla, Amr Almobayed, Carlos Mendoza
Zitieren
APA
Badla, O., Badla, B. A., Almobayed, A., Mendoza, C., Kishor, K., & Bhattacharya, S. K. (2024). Ischemic Optic Neuropathy: A Review of Current and Potential Future Pharmacotherapies. Pharmaceuticals, 17(10), 1281. https://doi.org/10.3390/ph17101281
Vancouver
Badla O, Badla BA, Almobayed A, Mendoza C, Kishor K, Bhattacharya SK. Ischemic Optic Neuropathy: A Review of Current and Potential Future Pharmacotherapies. Pharmaceuticals. 2024;17(10):1281. doi:10.3390/ph17101281
BibTeX
@article{Badla2024,
author = {Badla, Omar and Badla, Beshr Abdulaziz and Almobayed, Amr and Mendoza, Carlos and Kishor, Krishna and Bhattacharya, Sanjoy K},
title = {Ischemic Optic Neuropathy: A Review of Current and Potential Future Pharmacotherapies},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {10},
pages = {1281},
doi = {10.3390/ph17101281}
}
EUVIMED